Role of Probiotics as Adjunct Therapy Along With Standard Care in Decreasing Hospital Stay and Improving Symptoms in Pediatric Patients Admitted With Severe Pneumonia

Launched by SHAHEED ZULFIQAR ALI BHUTTO MEDICAL UNIVERSITY · Mar 20, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of probiotics—beneficial bacteria that can help improve gut health—when given alongside standard treatments for severe pneumonia in children. The goal is to see if adding probiotics can help reduce the time kids spend in the hospital and improve their symptoms, such as fever, rapid breathing, and cough.

Eligible participants for this trial are children aged between 2 months and 24 months who are experiencing severe pneumonia. Some children, however, cannot participate. For example, those with very severe pneumonia, severe malnutrition, other infections, or certain chronic health issues are excluded. If your child is eligible and joins the trial, they will receive standard care for pneumonia along with probiotics to see if this combination helps them recover more quickly. The trial is currently recruiting participants, and it’s an opportunity to contribute to important research that could benefit other children facing similar health challenges.

Gender

ALL

Eligibility criteria

• • Inclusion criteria Patient aged 2month-24months. Both male and female children
• Exclusion Criteria:
• • Patients with severe acute malnutrition Patients with very severe pneumonia Patients with Other concurrent infections Patients having any chronic debilitating condition Children who took probiotics in past 6 months Patient requiring mechanical ventilation